Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Dosing and Safety of Once-Weekly Rifapentine and Isoniazid for 12 Weeks for Tuberculosis Preventive Therapy in Children With and Without HIV: Protocol for a Phase I/II Open-Label, Exposure-Controlled, Dose-Finding, and Safety Study (Tuberculosis Trials Consortium Study 35). Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Unresolved reference
External reference
Risk factors for infection and disease in child contacts of multidrug-resistant tuberculosis: a cross-sectional study
10.1186/1471-2334-13-392 · External reference
The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis
10.1016/s0140-6736(20)30166-5 · External reference
Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis
10.1016/s1473-3099(16)30474-1 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice
10.1164/ajrccm/148.6_pt_1.1541 · External reference
Three months of rifapentine and isoniazid for latent tuberculosis infection
10.1056/nejmoa1104875 · External reference
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid
10.1001/jamapediatrics.2014.3158 · External reference
Pharmacokinetics and safety of rifapentine in children: dosing for latent tuberculosis infection
10.1093/jac/dkaf029 · External reference
Rifapentine pharmacokinetics and tolerability in children and adults treated once weekly with rifapentine and isoniazid for latent tuberculosis infection
10.1093/jpids/pit077 · External reference
Twice-weekly therapy for children with tuberculosis infection or exposure
10.5588/ijtld.12.0641 · External reference
Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial
10.1016/s2352-3018(20)30032-1 · External reference
Optimizing dosing and fixed-dose combinations of rifampicin, isoniazid, and pyrazinamide in pediatric patients with tuberculosis: a prospective population pharmacokinetic study
10.1093/cid/ciab908 · External reference
Pharmacokinetics of first-line drugs in children with tuberculosis, using World Health Organization–recommended weight band doses and formulations
10.1093/cid/ciab725 · External reference
Pharmacokinetics and safety of 3 months of weekly rifapentine and isoniazid for tuberculosis prevention in pregnant women
10.1093/cid/ciab665 · External reference
Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailability
10.1128/aac.01918-13 · External reference
Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy
10.1164/rccm.200311-1612oc · External reference
Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose
10.1038/psp.2013.24 · External reference
Pharmacokinetics of rifapentine in children
10.1097/01.inf.0000214963.55217.9c · External reference
Developmental pharmacology--drug disposition, action, and therapy in infants and children
10.1056/nejmra035092 · External reference
Mechanism-based concepts of size and maturity in pharmacokinetics
10.1146/annurev.pharmtox.48.113006.094708 · External reference
Mechanistic basis of using body size and maturation to predict clearance in humans
10.2133/dmpk.24.25 · External reference
Prediction of fat-free mass in children
10.1007/s40262-015-0277-z · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
